{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Petros Pharmaceuticals, Inc.
Is Petros Pharmaceuticals, Inc. technically bullish or bearish?
As of May 3, 2024, the technical trend has shifted to a bearish stance with moderate strength, supported by daily moving averages and weekly indicators, despite some mildly bullish signals from the MACD.
What does Petros Pharmaceuticals, Inc. do?
Petros Pharmaceuticals, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $1 million and a market cap of $0.93 million. Key metrics include a return on equity of 83.46% and a debt-to-equity ratio of 0.93.
How big is Petros Pharmaceuticals, Inc.?
As of Jun 18, Petros Pharmaceuticals, Inc. has a market capitalization of 0.93 million, with net sales of 3.73 million and a net profit of -13.35 million over the last four quarters. The company reported shareholder's funds of -7.47 million and total assets of 10.64 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
